These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Feasibilities of photodynamic therapy in the treatment of corneal mycotic lesions: an experimental study]. Mamikonian VR, Balaian ML, Budzinskaia MV, Strakhovskaia MV, Fedorov AA, Loshchenov VB, Shevchik SA, Negrimovskiĭ VM, Iuzhakova OA, Kuz'min SG, Vorozhtsov GN. Vestn Oftalmol; 2007; 123(5):25-8. PubMed ID: 18078054 [Abstract] [Full Text] [Related]
26. Effect of photodynamic therapy on anti-tumor immune defenses: comparison of the photosensitizers hematoporphyrin derivative and chloro-aluminum sulfonated phthalocyanine. Marshall JF, Chan WS, Hart IR. Photochem Photobiol; 1989 May; 49(5):627-32. PubMed ID: 2755999 [Abstract] [Full Text] [Related]
27. Feasibility of laser-targeted photoocclusion of the choriocapillary layer in rats. Asrani S, Zou S, D'Anna S, Lutty G, Vinores SA, Goldberg MF, Zeimer R. Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2702-10. PubMed ID: 9418722 [Abstract] [Full Text] [Related]
37. Enhanced tumour selectivity of photodynamic therapy in the rat colon using a radioprotective agent. Bedwell J, Chatlani PT, MacRobert AJ, Roberts JE, Barr H, Dillon J, Bown SG. Photochem Photobiol; 1991 Jun 01; 53(6):753-6. PubMed ID: 1653426 [Abstract] [Full Text] [Related]
38. Effect of aspirin on photodynamic therapy utilizing chloroaluminum sulfonated phthalocyanine (CASP). Stern SJ, Craig JR, Flock S, Small S. Lasers Surg Med; 1992 Jun 01; 12(5):494-9. PubMed ID: 1406001 [Abstract] [Full Text] [Related]